Diseases, Conditions, Syndromes

Hepatitis B: Natural controllers shed light on immunity mechanisms

Infections in humans caused by the hepatitis B virus (HBV) represent a major public health problem. Despite the availability of effective protective vaccines, more than 250 million individuals worldwide are chronically infected ...

Diseases, Conditions, Syndromes

Hospitalizations for chronic liver disease on the rise

(HealthDay)—Hospitalizations for chronic liver disease (CLD) increased from 2012 to 2016, reaching a total estimated national cost of $81.1 billion, according to a study published online April 2 in JAMA Network Open.

Diseases, Conditions, Syndromes

We have a vaccine for hepatitis B, but we still need a cure

Hepatitis B is blood-borne virus that packs a punch. Worldwide, more than 1.3 billion people have been infected with hepatitis B, and 257 million people have developed a life-long infection. This includes 240,000 Australians, ...

Diseases, Conditions, Syndromes

FDA warns of liver problems for some taking hep C drugs

(HealthDay)—Taking the hepatitis C drugs Mavyret, Zepatier or Vosevi can trigger rare cases of severe liver problems or liver failure in patients who already have moderate-to-severe liver impairment, the U.S. Food and Drug ...

page 7 from 35